Respiratory syncytial virus (RSV), is the single most important infectious cause of severe respiratory disease in infants. Infection begins when the virion attachment protein binds to a cellular receptor and the virion membrane fuses with the target cell membrane. RSV has three surface glycoproteins in a position to perform the attachment and fusion functions: G (glycoprotein), F (fusion), and the small hydrophobic (SH) protein. Laboratory strains of RSV attach to glycosaminoglycans (GAGs) to initiate infection, but this characteristic might be selected by passage in cultured cells. The first Specific Aim of this study will compare the viral glycoprotein gene sequences derived directly from patient samples to those from cultured virus from the same patient. The second Specific Aim will examine the ability of the RSV F protein to bind to target cells, an idea derived from the surprising fact that both the G and SH genes can be deleted from RSV without loss of infectivity. This characteristic, unique among paramyxoviruses, strongly suggests that the RSV F protein is able to attach to cells, and together with its well-established role in membrane fusion, to initiate infection. F protein attachment to target cells will be explored using radioactively labeled recombinant RSV virions that contain the F protein as their only viral glycoprotein. These viruses also express the green fluorescent protein (GFP), allowing easy assay of infectivity and determination of the efficiency of infection once the virus is bound. The third Specific Aim will identify the region(s) of the F protein involved in cell attachment and fusion, through blocking studies with Fspecific monoclonal antibodies and overlapping peptide libraries, and through targeted mutations in the F protein. These mutations will be incorporated into recombinant virions expressing GFP, and their ability to support infection tested. The overall goal of this project is to understand the entry mechanism of RSV for eventual use in designing antiviral agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI047213-05
Application #
6899043
Study Section
Virology Study Section (VR)
Program Officer
Rubin, Fran A
Project Start
2001-06-01
Project End
2006-04-30
Budget Start
2004-05-03
Budget End
2005-04-30
Support Year
5
Fiscal Year
2004
Total Cost
$291,999
Indirect Cost
Name
Nationwide Children's Hospital
Department
Type
DUNS #
147212963
City
Columbus
State
OH
Country
United States
Zip Code
43205
Costello, Heather M; Ray, William C; Chaiwatpongsakorn, Supranee et al. (2012) Targeting RSV with vaccines and small molecule drugs. Infect Disord Drug Targets 12:110-28
Chaiwatpongsakorn, Supranee; Epand, Raquel F; Collins, Peter L et al. (2011) Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer. J Virol 85:3968-77
Malykhina, Olga; Yednak, Mark A; Collins, Peter L et al. (2011) A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression. J Virol 85:4792-801
Hasman, Hatice; Pachucki, Constance T; Unal, Arife et al. (2009) Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4. J Med Microbiol 58:408-13
Kwilas, Steven; Liesman, Rachael M; Zhang, Liqun et al. (2009) Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. J Virol 83:10710-8
Hallak, Louay K; Kwilas, Steven A; Peeples, Mark E (2007) Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol Biol 379:15-34
Borrego-Diaz, E; Peeples, M E; Markosyan, R M et al. (2003) Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. Virology 316:234-44
Barretto, Naina; Hallak, Louay K; Peeples, Mark E (2003) Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection. Virology 313:33-43
Techaarpornkul, Sunee; Collins, Peter L; Peeples, Mark E (2002) Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 294:296-304
Techaarpornkul, S; Barretto, N; Peeples, M E (2001) Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J Virol 75:6825-34

Showing the most recent 10 out of 11 publications